この成分は何ですか?

이 원료는 다음의 구조를 갖는 탄화수소이다.

成分一覧

成分辞典

OCTENE

1-octene is an octene with an unsaturation C-1.

定義

1-octene is an octene with an unsaturation C-1.

出典: PubChem

米国FDA 物質登録 · UNII E5VK21B9RC · 登録名 Caprylene · 単一の化学物質

出典: 米国FDA 物質識別番号（UNII）

化粧品での役割

他の成分を溶かす基剤SOLVENT

安全性・規制情報

韓国の有害物質GHS分類: 危険 · H304 (区分1) · H400 (区分1) · H410 (区分1) · ほか1件

出典: 韓国有害物質GHS情報（環境公団）

詳しい資料 — 表示名・識別番号・物性・試験記録・文献

別名・識別情報

OCTENEINCI옥텐韓国の表示名（食薬処標準名）1-Octene別名

CAS No.化学物質登録番号: 111-66-0
EC No.EU化学物質目録番号: 203-893-7
DTXSID米国EPA化学物質番号: DTXSID6025804
DTXCID米国EPA化合物番号: DTXCID705804

IUPAC: Oct-1-ene
分子式: C8H16
分子量: 112.216 g/mol

測定された物性

性状: 1-octene appears as a colorless liquid. Flash point 70 °F. Insoluble in water and less dense (at about 6 lb / gal) than water. Hence floats on water. Vapors are heavier than air and may settle in depressions. Reported to biodegrade very slowly. Used in organic synthesis, surfactants, and plasticizers. · Liquid
沸点: 250.3 °F at 760 mmHg (USCG, 1999) · 121.2 °C @ 760 mm Hg
融点: -151 °F (USCG, 1999) · -101.7 °C
溶解性: Miscible with ethanol, ether · Miscible in ethanol, soluble in ethyl ether and acetone
密度: 0.715 at 68 °F (USCG, 1999) - Less dense than water, will float · 0.7149 @ 20 °C/4 °C
粘度: 0.656 cSt at 20 °C · 0.656 cSt (@ 20 ℃)
色: 無色
融点・凝固点: -102 ℃
初留点および沸点範囲: 123 ℃
引火点: 10 ℃(c.c.)
可燃性（固体、気体）: 引火性
燃焼・爆発範囲の上限/下限: 0.7 / 3.9 %
蒸気圧: 17.4 ㎜Hg (@ 25 ℃)
溶解度: 4.1 ㎎/ℓ (@ 25 ℃)
蒸気密度: 3.9
比重: 0.7149 (@ 20 ℃)
n-オクタノール/水分配係数（Kow）: 4.57
自然発火温度: 256 ℃
分子量: 112.22

物質そのものを測定した値です。安全保健公団（KOSHA）の資料はSDS作成・確認の参考用で、原料商品の規格ではありません。

出典: PubChem · 韓国安全保健公団 SDS

製品が実際に使っている用途

米国EPAにこの成分を届け出た製品15件の用途です。化粧品以外の製品も含まれるため、上の数行がこの成分の主な使い道といえます。

Monomers3
Intermediate3
Flavouring and nutrient2
Chemical reaction regulator2
Viscosity modifier2
Lubricating agent1
Fragrance1
Solvent1

出典: 米国EPA CompTox

刺激・感作試験の記録

皮膚試験17件・眼試験8件の記録があります。

刺激が強いと分類5件中程度と分類3件低いと分類31件

試験ごとに結論が分かれています（最も多い結論の割合 13%）。この成分が刺激性だとは言い切れないということです。原料そのものを試験した記録で、完成品に含まれる濃度での刺激性とは異なります。

試験25件をすべて見る

Studies Indicate No Significant Irritation
skin irritation: in vivo · Screening · OECD Guideline 404 (Acute Dermal Irritation / Corrosion) according to EU Method B.4 (Acute Toxicity: Dermal Irritation / Corrosion) according to EPA OTS 798.4470 (Acute Dermal Irritation) according to
Category 6.3A (Category 2)
Skin Irritation · Read Across
Studies Indicate No Significant Irritation
skin irritation: in vivo · Screening · OECD Guideline 404 (Acute Dermal Irritation / Corrosion) according to
Studies Indicate No Significant Irritation
skin irritation: in vivo · Screening · OECD Guideline 404 (Acute Dermal Irritation / Corrosion) equivalent or similar to
Studies Indicate No Significant Irritation
skin irritation: in vivo · Screening · other guideline: U.S. EPA FIFRA (Pesticide Assessment Guidelines Subdivision F/TSCA (798.4470) according to OECD Guideline 404 (Acute Dermal Irritation / Corrosion) according to
Severe Irritation
skin irritation: in vivo · Screening · OECD Guideline 404 (Acute Dermal Irritation / Corrosion) according to EU Method B.4 (Acute Toxicity: Dermal Irritation / Corrosion) according to EPA OTS 798.4470 (Acute Dermal Irritation) according to
Moderate or Mild Irritation
skin irritation: in vivo · Screening · OECD Guideline 404 (Acute Dermal Irritation / Corrosion) according to
Severe Irritation
skin irritation: in vivo · Screening · OECD Guideline 404 (Acute Dermal Irritation / Corrosion) according to
Studies Indicate No Significant Irritation
skin irritation: in vivo · Screening · OECD Guideline 404 (Acute Dermal Irritation / Corrosion) equivalent or similar to other guideline: 16 CFR 1500.41 according to
Studies Indicate No Significant Irritation
skin irritation: in vivo · Screening · other guideline: Federal Hazardous Substances Labeling Act (FHSLA) according to
Not likely to be sensitizing
skin sensitisation: in vivo (non-LLNA) · Screening · according to OECD Guideline 406 (Skin Sensitisation)
Studies Indicate No Significant Irritation
skin irritation: in vivo · Screening · OECD Guideline 404 (Acute Dermal Irritation / Corrosion) OPPTS 870.2500 according to
Studies Indicate No Significant Irritation
skin irritation: in vivo · Screening · other guideline: Federal Hazardous Substances Labelling Act (FHSLA) according to
Studies Indicate No Significant Irritation
skin irritation: in vivo · Screening · other guideline: Federal Hazardous Substance Labelling Act (FHSLA) according to
Not likely to be sensitizing
skin sensitisation: in vivo (non-LLNA) · Screening · equivalent or similar to OECD Guideline 406 (Skin Sensitisation)
Studies Indicate No Significant Irritation
skin irritation: in vivo · Screening · OECD Guideline 404 (Acute Dermal Irritation / Corrosion) according to EU Method B.4 (Acute Toxicity: Dermal Irritation / Corrosion) according to
Moderate or Mild Irritation
skin irritation: in vivo · Screening · OECD Guideline 404 (Acute Dermal Irritation / Corrosion) equivalent or similar to
Category 6.4A (Category 2A)
Eye Irritation · Read Across
Studies Indicate No Significant Irritation
eye irritation: in vivo · Screening · other guideline: Federal Hazardous Substances Labeling Act (FHSLA) according to
Studies Indicate No Significant Irritation
eye irritation: in vivo · Screening · OECD Guideline 405 (Acute Eye Irritation / Corrosion) equivalent or similar to
Studies Indicate No Significant Irritation
eye irritation: in vivo · Screening · other guideline: Federal Hazardous Substances Labelling Act according to
Studies Indicate No Significant Irritation
eye irritation: in vivo · Screening · other guideline: Federal Register 28 (110), 6.6.1963. paragraph 191.12 Test for eye irritants. according to
Not classified
Eye Irritation · Screening
Studies Indicate No Significant Irritation
eye irritation: in vivo · Screening · OECD Guideline 405 (Acute Eye Irritation / Corrosion) according to
Studies Indicate No Significant Irritation
eye irritation: in vivo · Screening · OECD Guideline 405 (Acute Eye Irritation / Corrosion) according to EU Method B.5 (Acute Toxicity: Eye Irritation / Corrosion) according to